Acupuncture as a adjuvant treatment for ischemic stroke--A Multicenter, Randomized Controlled Trial

The first affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1.Patients 3-14 days after ischemic stroke;
•2.18-75 years old Patients;
•3.Clear consciousness, stable vital signs, no obvious mental retardation, Mini-Mental State Examination score in the normal range (normal boundary value: illiteracy > 17, primary school > 20, junior high school and above > 24), can cooperate with acupuncture, rehabilitation training and related basic treatment;
•4.The score of modified Rankin scale (mRS) before stroke was less than 1, and the score of National Institutes of Health Stroke scale (NIHSS) after stroke was 5-15.
•5.Those who understand the test and sign the informed consent form.

•1.Transient ischemic attack, reversible neurological deficit;
•2.Patients confirmed by examination that the life expectancy of patients with neurological impairment caused by brain tumor, brain trauma, cerebral hemorrhage, cerebral parasite and other causes other than stroke is less than 1 year.
•3.Patients with acupuncture contraindications, or stroke patients with severe primary diseases such as circulatory system, respiratory system, digestive system, urinary system, endocrine system and hematopoietic system, which can not be controlled by routine medication; patients with tumors, patients with severe infection, water, electrolyte and acid-base balance disorders, or other abnormal researchers judged to be unsuitable to participate in this trial.
•4.Those with severe aphasia, sleep apnea, deafness, severe cognitive impairment and inability to communicate normally; or those who are participating in other clinical trials;
•5.Patients with severe depression, anxiety, or other mental disorders;
•6.Woman who is pregnant or plans to become pregnant.

发起方

The first affiliated Hospital of Guangzhou University of Chinese Medicine